Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$71.24 - $85.35 $647,927 - $776,258
-9,095 Reduced 78.81%
2,445 $208,000
Q4 2023

Feb 09, 2024

SELL
$80.59 - $92.61 $6,769 - $7,779
-84 Reduced 0.72%
11,540 $986,000
Q3 2023

Nov 09, 2023

BUY
$82.56 - $93.49 $105,181 - $119,106
1,274 Added 12.31%
11,624 $1.04 Million
Q1 2023

May 10, 2023

BUY
$72.75 - $90.6 $106,215 - $132,276
1,460 Added 16.42%
10,350 $856,000
Q4 2022

Feb 10, 2023

BUY
$73.85 - $86.14 $656,526 - $765,784
8,890 New
8,890 $699,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.38B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.